Lupin Bags USFDA Authorization For Fenofibrate; Zydus Cadila To Back Away From Drug Discovery Pact With Eli Lilly
Mon, 01/02/2012 - 07:49 | 
Lupin Pharmaceuticals Ltd has bagged final authorization for its Fenofibrate Tabs, 48 mg and 145 mg potencies from
the USFDA.
Teva Pharmaceutical Industries Ltd stated that President and Chief Executive Shlomo Yanai would quit during May, after over 5 years at the helm.
Research based Indian pharma firms are ready to detain a key share of the US domestic market with growing number of filing of ANDAs.
Indian pharmaceutical firm, Zydus Cadila is eyeing to back out from its alliance with Eli Lilly, which involved combined drug detection for cardiovascular illnesses.
Tags: 